Lee Flowers
CIK: 0001866254
Transaction Breakdown
Open Market Buys (P)2 (100.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)0 (0.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
HCWB
HCW Biologics Inc.
Officer
Discretionary Trading P&L
Holdings
About Flowers Lee
Flowers Lee (SEC CIK 0001866254) files insider reports with the SEC as SVP of Business Development of HCW Biologics Inc. (HCWB).
Signal8 holds 1 ownership filing by Flowers Lee, a Form 4, filed on May 9, 2025. Those filings report 2 transactions, from May 7, 2025 to May 8, 2025. Signal8's Form 4 history starts in Sep 2024.
The business address on Flowers Lee's filings is in MIRAMAR, FL.
Recent filings by Flowers Lee
Other insiders filing for HCW Biologics Inc. (HCWB)
- Wong Hing C, Chief Executive Officer
- GARRETT SCOTT T, Director
- Byam Rebecca, Chief Financial Officer
- Winer Gary M, Director
- Greene Rick S., Director